Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Molecular Immunology

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0161-5890(00)00038-9PMID 10865109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibody variable region glycosylation: biochemical and clinical effects

  2004cited by this paper
• Characteristics of Human IgA and IgM Genes Used by Plasma Cells in the Salivary Gland Resemble Those Used in Duodenum But Not Those Used in the Spleen1

  2000cited by this paper
• Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1-->6) dextran antibody.

  1999cited by this paper
• Characteristics of IgVH genes used by human intestinal plasma cells from childhood

  1999cited by this paper
• Strong intrinsic biases towards mutation and conservation of bases in human IgVH genes during somatic hypermutation prevent statistical analysis of antigen selection

  1998cited by this paper
• Base-specific sequences that bias somatic hypermutation deduced by analysis of out-of-frame human IgVH genes.

  1998cited by this paper
• The Glycosylation and Structure of Human Serum IgA1, Fab, and Fc Regions and the Role of N-Glycosylation on Fcα Receptor Interactions*

  1998cited by this paper
• Hypermutation, diversity and dissemination of human intestinal lamina propria plasma cells

  1997cited by this paper
• Targeting of non-lg sequences in place of the V segment by somatic hyper mutation

  1995cited by this paper
• Analysis of Ig VH region genes encoding IgE antibodies in splenic B lymphocytes of a patient with asthma.

  1995cited by this paper
• Targeting of non-Ig sequences in place of the V segment by somatic hypermutation.

  1995cited by this paper
• Germinal centers.

  1994cited by this paper
• Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis.

  1992cited by this paper
• The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops.

  1992cited by this paper
• Intraclonal generation of antibody mutants in germinal centres

  1991cited by this paper
• Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure.

  1991cited by this paper
• Glycosylation of a VH residue of a monoclonal antibody against alpha (1- ---6) dextran increases its affinity for antigen

  1988cited by this paper

• Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy

  2025cites this paper
• Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies.

  2025cites this paper
• Altered IgG N-Glycosylation at Onset of Type 1 Diabetes in Children Is Predominantly Driven by Changes in the Fab N-Glycans

  2025cites this paper
• In silico evaluation of the role of Fab glycosylation in cetuximab antibody dynamics

  2024cites this paper
• Escherichia coli and Pichia pastoris: microbial cell-factory platform for full-length IgG production

  2024cites this paper
• The role of antibody glycosylation in autoimmune and alloimmune kidney diseases

  2024cites this paper
• Predicting Biochemical and Physiological Parameters: Deep Learning from IgG Glycome Composition

  2024cites this paper
• Pathogenic role of anti‐nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases

  2024cites this paper
• Unveiling the multifaceted landscape of N-glycosylation in antibody variable domains: Insights and implications.

  2023cites this paper
• IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy.

  2023cites this paper
• Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics Perspective

  2022cites this paper
• Glycobiology of rheumatic diseases

  2022cites this paper
• Mutational patterns along different evolution paths of follicular lymphoma

  2022cites this paper
• Immunoglobulin G glycans - biomarkers and molecular effectors of aging.

  2022cites this paper
• An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis

  2022cites this paper
• Changes of IgG N-Glycosylation in Thyroid Autoimmunity: The Modulatory Effect of Methimazole in Graves’ Disease and the Association With the Severity of Inflammation in Hashimoto’s Thyroiditis

  2022influential citation
• Atypical N-glycosylation of SARS-CoV-2 impairs the efficient binding of Spike-RBM to the human-host receptor hACE2

  2021cites this paper
• Human IgG Glycosylation in Inflammation and Inflammatory Disease

  2021cites this paper
• Micro-Heterogeneity of Antibody Molecules.

  2021cites this paper
• Lectin and Liquid Chromatography-Based Methods for Immunoglobulin (G) Glycosylation Analysis.

  2021cites this paper
• Immunoglobulin G Glycosylation in Diseases.

  2021cites this paper
• Elevated N-Linked Glycosylation of IgG V Regions in Myasthenia Gravis Disease Subtypes

  2021cites this paper
• The Importance of Glycosylation in COVID-19 Infection.

  2021cites this paper
• Glycosylation and Aging.

  2021cites this paper
• Immunoglobulin germline gene variation and its impact on human disease

  2021cites this paper
• B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells

  2021cites this paper
• Systems Glycobiology: Immunoglobulin G Glycans as Biomarkers and Functional Effectors in Aging and Diseases

  2021cites this paper
• New insights of glycosylation role on variable domain of antibody structures

  2021influential citation
• Elevated N-glycosylation of immunoglobulin G variable regions in myasthenia gravis highlights a commonality across autoantibody-associated diseases

  2021cites this paper
• Minimal B Cell Extrinsic IgG Glycan Modifications of Pro- and Anti-Inflammatory IgG Preparations in vivo

  2020cites this paper
• N-glycans as functional effectors of genetic and epigenetic disease risk.

  2020cites this paper
• Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire.

  2020cites this paper
• B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making

  2020cites this paper
• Protective Activities of Mucosal Antibodies

  2020cites this paper
• Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis

  2019cites this paper
• The role of variable domain glycosylation of antibodies in immunity

  2019cites this paper
• IgG Glycans as a Biomarker of Biological Age

  2019cites this paper
• Glycosylation as an Important Regulator of Antibody Function

  2019cites this paper
• Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a

  2018cites this paper
• The Mechanism of Swainsonine Causing Early Pregnancy Abnormal Decidualization and Inducing Abortion by Changing Glycosylation Modification

  2018cites this paper
• Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region

  2018cites this paper
• Immunoglobulin G glycosylation in aging and diseases.

  2018cites this paper
• Variable Domain N-Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody Stability

  2018cites this paper
• Variable domain glycosylation of ACPA-IgG: A missing link in the maturation of the ACPA response?

  2017cites this paper
• B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation

  2017cites this paper
• Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

  2017cites this paper
• Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies

  2016cites this paper
• Recent Advances in Clinical Glycoproteomics of Immunoglobulins (Igs)*

  2016cites this paper
• Production d'IgG sialylées en CHO et impact sur leurs fonctions effectrices

  2016cites this paper
• N-glycoprotein macroheterogeneity: biological implications and proteomic characterization

  2016cites this paper
• The Emerging Importance of IgG Fab Glycosylation in Immunity

  2016cites this paper
• Characterization of Therapeutic Proteins

  2016cites this paper
• Glands of Primary Sjögren's Syndrome Pressures on Ig-Producing Cells in Parotid Ig Gene Analysis Reveals Altered Selective

  2015cites this paper
• Man-made antibodies and immunoconjugates with desired properties: function optimization using structural engineering

  2015cites this paper
• Best Practices in Assessing the Developability of Biopharmaceutical Candidates

  2015cites this paper
• Ig Gene Analysis Reveals Altered Selective Pressures on Ig-Producing Cells in Parotid Glands of Primary Sjögren’s Syndrome Patients

  2015cites this paper
• Chapter 17 – Mucosal Immunoglobulins

  2015cites this paper
• Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity

  2014cites this paper
• Immunoglobulin light chains in Systemic Lupus Erythematosus

  2013influential citation
• A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties

  2013cites this paper
• Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies

  2012cites this paper
• Engineering the variable region of therapeutic IgG antibodies

  2011cites this paper
• Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces.

  2010cites this paper
• Structure and function of immunoglobulins.

  2010cites this paper
• pecific antibody activity , glycan heterogeneity and polyreactivity contribute to he protective activity of SIgA at mucosal surfaces

  2009cites this paper
• Chapter 4. Antibody Glycosylation

  2009cites this paper
• Glycosylation of Recombinant Antibody Therapeutics

  2008cites this paper
• Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice.

  2008cites this paper
• Lymphatic targeting of immuno-PEG-liposomes: evaluation of antibody-coupling procedures on lymph node macrophage uptake.

  2008cites this paper
• Characterization of a novel modification on IgG2 light chain. Evidence for the presence of O-linked mannosylation.

  2007cites this paper
• 4.20 – Human IgG Glycosylation in Inflammation and Inflammatory Disease

  2007cites this paper
• Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.

  2007cites this paper
• Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization.

  2006cites this paper
• Chapter 9 – Mucosal Immunoglobulins

  2005cites this paper
• Mucosal immunoglobulins

  2005cites this paper
• Glycosylation of natural and recombinant antibody molecules.

  2005cites this paper
• 20 The Role of Glycosylation in Engineered Antibodies

  2005cites this paper
• ExpressionV Region Carbohydrate and Antibody

  2004cites this paper
• Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignancies.

  2004cites this paper
• V Region Carbohydrate and Antibody Expression1

  2004cites this paper
• Incidence of novel N‐glycosylation sites in the B‐cell receptor of lymphomas associated with immunodeficiency

  2004cites this paper
• Intestinal Immunoglobulin A: Role in Host Defense

  2003cites this paper
• Somatic Hypermutation Patterns in Germinal Center B Cell Malignancies

  2003cites this paper
• Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma.

  2002cites this paper